Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
🔒 NordVPN Premium – 3 Months
hrdilshan
Updated:
Thursday at 8:29 PM
🚀 Microsoft Office 365 Pro Plus – Lifetime Access! 🚀
hrdilshan
Updated:
Thursday at 8:28 PM
Linkedin Premium Business / Careere /Sales Navigator - 1/2/3/6/9/12 Months - Reddem Link
hrdilshan
Updated:
Thursday at 8:27 PM
Colombo
YEYE 3 in 1 Instant Coffee Mix 50 Sachet
Romeshka
Updated:
Wednesday at 12:16 AM
Colombo
Red Hat Certified System Administrator (RHCSA) - RHEL 10
Sanjeewani95
Updated:
Jul 3, 2026
Electronics
Vehicles
Property
Search
Reply to thread
Forums
ElaKiri.com
News and Updates
🔴 BREAKING 🔥
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 27999148" data-attributes="member: 562115"><p>The WHO follows what's called "International Health Regulations" (IHR) that guides the response to emerging threats. Under this they can issue a <strong>PHEIC</strong> - “Public Health Emergency of International Concern”.</p><p>On June 23rd they decided that Monkeypox didn't fit the criteria for a PHEIC. But now, even though the panel did not come to a consensus, the Director General has issued a PHEIC. Many are divided over this decision.</p><p></p><p>Monkeypox in all probability<strong> will not escalate</strong> into a pandemic situation even though the case numbers are increasing. This is because <strong>Monkeypox does not spread as fast</strong> as SARS-Cov2 and the community spread can be controlled.</p><p>Monkeypox virus belongs to the <em>Poxviridae</em>, a family of viruses that also includes cowpox virus, variola virus (smallpox), and vaccinia virus (the source of the modern smallpox vaccine). Although it was found in primates, it is believed that even some rodents can carry it.</p><p></p><p>Human to human transmission of monkeypox is only thought to be transmitted while symptomatic. (Unlike Covid which is transmitted while asymptomatic). Hence the efficiency of transmission is much less than of Covid.</p><p>Also even though the spread was reported among the gay community, there's no evidence that the pathogen is present in sexual body fluids. Hence the spread is because of close contact.</p><p></p><p>The incubation period for monkeypox virus can range from 5 to 21 days, with an average of one week between infection and onset of symptoms.</p><p>There are two licensed <strong>smallpox-specific vaccines that can also prevent monkeypox</strong>.</p><p></p><p><strong>ACAM2000 - replication-<em>competent</em> live-attenuated vaccinia virus</strong> developed by Sanofi Pasteur Biologics Co. It's very effective but associated with pretty severe side effects, including sore arm, fever, body aches, and occasional myocarditis.</p><p></p><p><strong>MVA-BN </strong>(marketed as <strong>“Jynneos”</strong> ) is a <strong>highly attenuated replication-</strong><em><strong>incompeten</strong>t</em> vaccinia virus produced by Bavarian Nordic. MVA-BN/Jynneos is delivered by injection under the skin, is much better tolerated than ACAM2000, and is approved to be used as a monkeypox-specific vaccine.</p><p></p><p>Note that, because of the long incubation period, it is possible to be vaccinated shortly after an exposure to monkeypox virus and still be protected.</p><p></p><p>There are also several FDA-approved antiviral drugs that could be effective against monkeypox virus infection. Tecovirimat, (oral drug), prevents release of newly formed viral particles from infected cells, thus blocking transmission.</p><p>Cidofovir (infusion into the vein) and its derivative Brincidofovir (taken orally), disrupt replication of smallpox virus and could thus also be used for treating monkeypox. </p><p></p><p>Some countries (Canada, US & the UK) have adopted the so called "Ring Vaccination" strategy. - administering the vaccine to contacts and contacts of contacts of an infected person.</p><p>The CDC recently reported genomic data showing that there are at least <strong>two strains</strong> of the monkeypox virus responsible for the outbreaks. The current outbreak is from the West African clade (which is less severe with CFR 3.6%) compared with the Congo Basin Clade (CFR 10.6%)</p><p></p><p>The WHO is concerned that this time the outbreak presents with <strong>atypical clinical symptoms</strong>. Unlike before, this time there are cases with -</p><p></p><p>Presentation of only a few or even just a single lesion</p><p>Absence of skin lesions in some cases, with anal pain and bleeding</p><p>Lesions in the genital or perineal/perianal area which do not spread further</p><p>Lesions appearing at different (asynchronous) stages of development etc</p><p></p><p>Hence a worry that there could be many undetected cases which has led to an underestimation of the actual count. Hence the alert and the need for health professionals to be more watchful.</p><p></p><p>PS: I wrote the following on a different thread...</p><p></p><p><strong>"The waning population immunity associated with discontinuation of smallpox vaccination has established the landscape for the resurgence of monkeypox. </strong>The smallpox vaccine provided the <strong>cross protection</strong> for <strong>monkeypox</strong>."</p></blockquote><p></p>
[QUOTE="imhotep, post: 27999148, member: 562115"] The WHO follows what's called "International Health Regulations" (IHR) that guides the response to emerging threats. Under this they can issue a [B]PHEIC[/B] - “Public Health Emergency of International Concern”. On June 23rd they decided that Monkeypox didn't fit the criteria for a PHEIC. But now, even though the panel did not come to a consensus, the Director General has issued a PHEIC. Many are divided over this decision. Monkeypox in all probability[B] will not escalate[/B] into a pandemic situation even though the case numbers are increasing. This is because [B]Monkeypox does not spread as fast[/B] as SARS-Cov2 and the community spread can be controlled. Monkeypox virus belongs to the [I]Poxviridae[/I], a family of viruses that also includes cowpox virus, variola virus (smallpox), and vaccinia virus (the source of the modern smallpox vaccine). Although it was found in primates, it is believed that even some rodents can carry it. Human to human transmission of monkeypox is only thought to be transmitted while symptomatic. (Unlike Covid which is transmitted while asymptomatic). Hence the efficiency of transmission is much less than of Covid. Also even though the spread was reported among the gay community, there's no evidence that the pathogen is present in sexual body fluids. Hence the spread is because of close contact. The incubation period for monkeypox virus can range from 5 to 21 days, with an average of one week between infection and onset of symptoms. There are two licensed [B]smallpox-specific vaccines that can also prevent monkeypox[/B]. [B]ACAM2000 - replication-[I]competent[/I] live-attenuated vaccinia virus[/B] developed by Sanofi Pasteur Biologics Co. It's very effective but associated with pretty severe side effects, including sore arm, fever, body aches, and occasional myocarditis. [B]MVA-BN [/B](marketed as [B]“Jynneos”[/B] ) is a [B]highly attenuated replication-[/B][I][B]incompeten[/B]t[/I] vaccinia virus produced by Bavarian Nordic. MVA-BN/Jynneos is delivered by injection under the skin, is much better tolerated than ACAM2000, and is approved to be used as a monkeypox-specific vaccine. Note that, because of the long incubation period, it is possible to be vaccinated shortly after an exposure to monkeypox virus and still be protected. There are also several FDA-approved antiviral drugs that could be effective against monkeypox virus infection. Tecovirimat, (oral drug), prevents release of newly formed viral particles from infected cells, thus blocking transmission. Cidofovir (infusion into the vein) and its derivative Brincidofovir (taken orally), disrupt replication of smallpox virus and could thus also be used for treating monkeypox. Some countries (Canada, US & the UK) have adopted the so called "Ring Vaccination" strategy. - administering the vaccine to contacts and contacts of contacts of an infected person. The CDC recently reported genomic data showing that there are at least [B]two strains[/B] of the monkeypox virus responsible for the outbreaks. The current outbreak is from the West African clade (which is less severe with CFR 3.6%) compared with the Congo Basin Clade (CFR 10.6%) The WHO is concerned that this time the outbreak presents with [B]atypical clinical symptoms[/B]. Unlike before, this time there are cases with - Presentation of only a few or even just a single lesion Absence of skin lesions in some cases, with anal pain and bleeding Lesions in the genital or perineal/perianal area which do not spread further Lesions appearing at different (asynchronous) stages of development etc Hence a worry that there could be many undetected cases which has led to an underestimation of the actual count. Hence the alert and the need for health professionals to be more watchful. PS: I wrote the following on a different thread... [B]"The waning population immunity associated with discontinuation of smallpox vaccination has established the landscape for the resurgence of monkeypox. [/B]The smallpox vaccine provided the [B]cross protection[/B] for [B]monkeypox[/B]." [/QUOTE]
Insert quotes…
Verification
Haya warak paha keeyada? (haya wadi kireema paha)
Post reply
Top
Bottom